Shannon L. Winski

MedicineBiochemistry, Genetics and Molecular BiologyPharmacology, Toxicology and Pharmaceutics

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 4 papers. Top paper: “Anti-tumor efficacy of a potent and selective non-covalent KRASG12D inhibitor”.

Anti-tumor efficacy of a potent and selective non-covalent KRASG12D inhibitor

Nature Medicine(2022)10.1038/s41591-022-02007-7

N/A

0DataRank · unranked

519 citations

Vickie Bowcut, Andrew Calinisan, David M. Briere, Lauren Hargis, Lars D. Engstrom +25 more

MEK inhibition enhances presentation of targetable MHC-I tumor antigens in mutant melanomas

Proceedings of the National Academy of Sciences(2022)10.1073/pnas.2208900119

N/A

0DataRank · unranked

38 citations

Nicholas J. Rettko, Owen Leddy, Joshua M. Mesfin, Eric N. Brown, Shannon L. Winski +4 more

MEK inhibition enhances presentation of targetable MHC-I tumor antigens in mutant melanomas

bioRxiv (Cold Spring Harbor Laboratory)(2022)10.1101/2022.01.10.475285

N/A

0DataRank · unranked

2 citations

Nicholas J. Rettko, Owen Leddy, Joshua M. Mesfin, Eric N. Brown, Shannon L. Winski +4 more

A Non-covalent KRASG12D Allele Specific Inhibitor Demonstrates Potent Inhibition of KRAS-dependent Signaling and Regression of KRASG12D-mutant Tumors

Research Square(2022)10.21203/rs.3.rs-1261963/v1

N/A

0DataRank · unranked

1 citations

Jill Hallin, Vickie Bowcut, Andrew Calinisan, David M. Briere, Lauren Hargis +25 more